Status:
ACTIVE_NOT_RECRUITING
Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking
Lead Sponsor:
Fred Hutchinson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
American Cancer Society, Inc.
Conditions:
Hematopoietic and Lymphoid System Neoplasm
Malignant Solid Neoplasm
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This phase III trial compares the Quit2Heal smoking cessation smartphone application (app) to the QuitGuide app in helping cancer patients quit smoking. Both apps provide tools to cope with urges to s...
Detailed Description
OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients receive the Quit2Heal app and are encouraged to use it frequently. During the entire 12-month follow-up period, the app will remain fu...
Eligibility Criteria
Inclusion
- Age 18 or older
- Diagnosed with cancer within the past 24 months or currently receiving or planning to receive cancer treatment in the next 3 months
- Smoked a cigarette (even a puff) in the past 30 days
- Interested in learning skills to quit smoking
- Willing to be randomly assigned to either smartphone application
- Live in the United States and will remain in the United States (US) for the next 12 months
- Have at least daily access to their own smartphone
- Know how to download a smartphone application
- Be willing and able to read English
- Not currently (i.e., within past 30 days) using other smoking cessation interventions
- Have never participated in our prior research trials
- Have never used the National Cancer Institute (NCI)'s QuitGuide app
- Being willing to complete a follow-up survey at 3, 6, and 12 months post-randomization
- Providing email, phone number(s), and mailing address
Exclusion
- Currently (i.e., within past 30 days) using other smoking cessation interventions
- Has participated in our prior research trials
- Has used the NCI's QuitGuide app
- Not willing to complete a follow-up survey at 3, 6, and 12 months post-randomization
- Not providing email, phone number(s), and mailing address
Key Trial Info
Start Date :
July 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 11 2026
Estimated Enrollment :
427 Patients enrolled
Trial Details
Trial ID
NCT04409236
Start Date
July 19 2021
End Date
September 11 2026
Last Update
September 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States, 98109